Actos Lawsuit Attorney
Actos & Bladder Cancer, Heart Failure, and Kidney Disease
The Food and Drug Administration approved Actos for oral use in 1999. Developed by Takeda Pharmaceutical for diabetes patients, it was designed to help control blood sugar levels. It became a massive hit, eventually becoming almost a third of Takeda’s annual revenue with $3.6 billion in sales in 2010 alone.
However, the drug also became linked to bladder cancer, heart failure, and kidney disease. In fact, Takeda knew prior to releasing the drug about the possible risks to bladder health—however, it still believed that the benefits outweighed the risks. If you were harmed as a result of taking Actos or similar drugs, contact The Simon Law Firm, P.C. We have the resources, skill, and experience to fight for you to receive just compensation for your injuries.
Speak with the seasoned drug injury attorneys at The Simon Law Firm, P.C. by scheduling a free consultation.
Symptoms of Harm from Actos
Actos possesses an active chemical that the FDA has labeled a possible cause of heart failure. However, Actos is primarily facing litigation over its links to bladder cancer. People who take Actos for a year can increase their odds of developing bladder cancer by 40-80 percent over those who do not take it at all. The FDA required Takeda to change all Actos labels to reflect this risk in 2011.
The symptoms of bladder cancer include:
- Bloody urine
- Painful urination
- Unusual back pain
- Increased need to urinate